Delivery Order #SPE2DR26FR9KW

AmerisourceBergen Awarded Delivery Order for Ondansetron Vials

This award represents a delivery order contract under a broader indefinite delivery vehicle with AmerisourceBergen Drug Corp, a leading healthcare services and pharmaceutical distribution company. The contract specifies the procurement of Ondansetron HCL 4 mg/2 ml vials, a medication commonly used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. This procurement supports the agency's pharmaceutical supply needs, ensuring the availability of critical medications for patient care. The work involves the supply and timely delivery of these specific pharmaceutical products, essential for ongoing medical treatments. This contract was awarded as part of a competitive framework established under the parent indefinite delivery vehicle, reflecting continued partnership and trust in AmerisourceBergen's distribution capabilities. The contract covers a short, defined period in early 2026, indicating a focused and timely fulfillment of the agency's pharmaceutical requirements.

Description

4571118583!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML

View original record